Local

Underwood talks diabetes drug prices

U.S. Congresswoman Lauren Underwood prepares to address attendees of her press conference on the affect of the high price of diabetes medication on Monday, July 15, 2019, at Edward Outpatient Center in Plainfield, Ill.  Congresswoman Underwood recently released a report detailing the affect on how the high price of diabetes medication have impacted families, seniors and the uninsured.
U.S. Congresswoman Lauren Underwood prepares to address attendees of her press conference on the affect of the high price of diabetes medication on Monday, July 15, 2019, at Edward Outpatient Center in Plainfield, Ill. Congresswoman Underwood recently released a report detailing the affect on how the high price of diabetes medication have impacted families, seniors and the uninsured.

U.S. Rep. Lauren Underwood, D-Naperville, recently released a report on the prices of diabetes drugs for seniors and uninsured Americans.

Underwood on Monday discussed the report’s findings and highlighted the stories of residents in the 14th Congressional District at a news conference at the Edward Hospital Campus in Plainfield. Those residents said they are struggling to pay for diabetes drugs. Over the past two decades, drug manufacturers have raised the price of insulin products more then tenfold, according to the report.

“Sky-high prices are unjustified, to say the least,” Underwood said.

She said that three manufacturers control about 96% of the market, and they often set prices in lockstep. The report also found that an estimated 15,000 Medicare beneficiaries in the district with diabetes are paying anywhere from two to five times as much for their prescription drugs than they would if they lived in Australia, the U.K. or Canada. And for the estimated 36,000 uninsured residents of the 14th District, their costs for popular insulin brands could be as much as 13 to 23 times the amount they would pay in those same countries.

Naperville resident Bill Schrier said with all of the prescriptions needed for his wife and two children who have Type 1 diabetes, their medical costs have quadrupled in just the past four years. He said the exorbitant costs have kept them from being able to buy the drug brands his children prefer.

“Like many Americans with Type 1 diabetes, we’ve had to make sacrifices and make do with what we can afford,” Schrier said.

The report identified at least one reason why drug prices have increased. The report found that seniors pay more, in part, because of Medicare’s lack of authority to directly negotiate with manufacturers for lower prices.

Underwood said there are many reforms “on the table” that could pass the House of Representatives. She acknowledged the Trump administration has made some efforts to implement reforms, such as expanding its ability to negotiate with manufacturers, but, she said, her Democratic colleagues in the House stand ready to pass actual legislation if the Republican-controlled Senate decides to act.

Darcy Tellone of Yorkville fought back tears talking about how Type 1 diabetes has affected her daughter, Lila, 11, and described the urgency with which she wants to see legislators act to fix the problem.

“There’s all this talk, but there’s no action, and so it’s very, very frustrating,” Tellone said. “That’s just something that I can’t bear to see anymore.”

Loading more

Digital Access

Digital Access
Access nwherald.com and all Shaw Media Illinois content from all your digital devices and receive breaking news and updates from around the area.

Home Delivery

Home Delivery
Local news, prep sports, Chicago sports, local and regional entertainment, business, home and lifestyle, food, classified and more! News you use every day! Daily, weekend and Sunday packages.

Text Alerts

Text Alerts
Stay connected to us wherever you are! Get breaking news updates along with other area information sent to you as a text message to your wireless device.

Email Newsletters

Email Newsletters
We'll deliver news & updates to your inbox. Plan your weekend and catch up on the news with our newsletters.